1.
Klin Med (Mosk)
; 79(9): 61-4, 2001.
Artículo
en Ruso
| MEDLINE
| ID: mdl-11641942
RESUMEN
Nine patients with moderate and severe aspirin bronchial asthma (ABA) received epifamine (a course dose 400 mg) in addition to continuous antiasthmatic therapy. Matched 12 ABA patients received placebo. Epifamine was found to improve the patients' clinical condition, response of distal bronchi to berotek; to promote achievement of long remission and increased production of melatonin. Thus, epifamine is effective and can be used in pathogenetic strategic therapy of ABA.